The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .
2 results for ibd
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection